MRB on Ecns – March 11, 202
Investors cannot fully assess the situation of COVID-19 infections in the United States as the cases are underreported due in part to the lack of testing, and that credible solutions are absent, Phillip Colmar, managing partner on global strategy with MRB Partners, told Xinhua.
“We’re gonna see a lot more volatility in the markets,” he said.